首页> 外文期刊>The Journal of the American Academy of Orthopaedic Surgeons >Synthesis, state-of-the-art NMR-binding and molecular modeling study of new benzimidazole core derivatives as Pin1 inhibitors: Targeting breast cancer
【24h】

Synthesis, state-of-the-art NMR-binding and molecular modeling study of new benzimidazole core derivatives as Pin1 inhibitors: Targeting breast cancer

机译:新苯并咪唑核心衍生物作为Pin1抑制剂的合成,最先进的NMR结合和分子建模研究:靶向乳腺癌

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

New series of benzimidazole ring core conjugated with either dithiocarbamate or thiopropyl linkers, hybridized with different secondary amines were synthesized; 5-15 and 22-31; respectively. The new compounds were characterized by different spectroscopic techniques (H-1, C-13 1D & 2D NMR, ESI-MS and IR). They were screened for in vitro anticancer activity against breast cancer using MCF7 cell line. The results obtained revealed that compounds 5, 12, 15 and 25 were the most active among the synthesized series exhibiting IC50 < 10 mu g/ml against DOX. To characterize targeting breast cancer on molecular level, binding to N-15-labeled Pin1 enzyme was conducted using state-of-the-art 2D NMR binding experiments. Results showed promising binding between compounds 5, 12, and 25 by chemical shift perturbation (peak shifting or peak disappearance). Molecular docking study were quite valuable to explain the binding mode of active derivatives via hydrogen bonding. Additional contact preferences and surface mapping studies stated the similarity pattern between active candidates which may pave the way for more precise anti breast cancer target optimization.
机译:合成与二硫代氨基甲酸酯或硫代丙酯或硫代丙基接头缀合的新系列苯并咪唑环核心; 5-15和22-31;分别。通过不同的光谱技术(H-1,C-13 1D和2D NMR,ESI-MS和IR)表征新化合物。使用MCF7细胞系筛选它们对乳腺癌的体外抗癌活性。得到的结果表明,化合物5,12,15和25是合成系列中最活性的,其具有对DOX的IC50 <10μg/ mL。为了在分子水平上表征靶向乳腺癌,使用最先进的2D NMR结合实验进行与N-15标记的PIN1酶的结合。结果表明,化合物5,12和25之间的有希望的结合通过化学换档扰动(峰值移位或峰消失)。分子对接研究通过氢键解释活性衍生物的结合模式非常有价值。额外的联系人偏好和表面映射研究表明,活性候选者之间的相似性模式,可以为更精确的抗乳腺癌目标优化铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号